OXAGEN

oxagen-logo

Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom.

#SimilarOrganizations #People #Financial #Website #More

OXAGEN

Industry:
Biopharma Biotechnology Health Care Pharmaceutical

Founded:
1997-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.oxagen.co.uk

Total Employee:
51+

Status:
Active

Contact:
44 12 3584 1561

Email Addresses:
[email protected]

Total Funding:
130.74 M USD

Technology used in webpage:
SPF Nginx Microsoft Exchange Online Office 365 Mail Fasthosts DNS Fasthosts


Similar Organizations

apogenix-logo

Apogenix

Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.


Current Advisors List

john-bell_image

John Bell Development Advisory Board Chairman @ Oxagen
Advisor

anja-kรถnig_image

Anja Kรถnig Board Positions @ Oxagen
Board_member

john-bell_image

John Bell Non-Executive Director @ Oxagen
Board_member

Current Employees Featured

john-bell_image

John Bell
John Bell Co-Founder @ Oxagen
Co-Founder

mark-payton_image

Mark Payton
Mark Payton CEO @ Oxagen
CEO

graham-boulnois_image

Graham Boulnois
Graham Boulnois Chairman and a Director @ Oxagen
Chairman and a Director

Founder


john-bell_image

John Bell

Investors List

abingworth-management_image

Abingworth

Abingworth investment in Series C - Oxagen

mpm-capital_image

MPM Capital

MPM Capital investment in Series C - Oxagen

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series C - Oxagen

international-biotechnology-trust_image

International Biotechnology Trust

International Biotechnology Trust investment in Series C - Oxagen

advent-venture-partners_image

Advent Venture Partners

Advent Venture Partners investment in Series C - Oxagen

red-abbey-venture-partners_image

Red Abbey Venture Partners

Red Abbey Venture Partners investment in Series C - Oxagen

omega-funds_image

Omega Funds

Omega Funds investment in Series C - Oxagen

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series C - Oxagen

bessemer-venture-partners_image

Bessemer Venture Partners

Bessemer Venture Partners investment in Series C - Oxagen

wellcome-trust_image

Wellcome Trust

Wellcome Trust investment in Series C - Oxagen

Official Site Inspections

http://www.oxagen.co.uk

  • Host name: 104.247.81.53
  • IP address: 104.247.81.53
  • Location: Canada
  • Latitude: 43.6319
  • Longitude: -79.3716
  • Timezone: America/Toronto

Loading ...

More informations about "Oxagen"

OXAGEN LIMITED overview - Find and update company โ€ฆ

Charges for OXAGEN LIMITED (03246469) Insolvency for OXAGEN LIMITED (03246469) More for OXAGEN LIMITED (03246469) Registered office address C/O CORK GULLY LLP, 6 Snow โ€ฆSee details»

Oxagen 2025 Company Profile: Valuation, Funding & Investors

Oxagen General Information Description. Developer of small molecule drugs designed to treat inflammatory and respiratory diseases. The company's drugs comprise an oral anti โ€ฆSee details»

Oxagen - VentureRadar

Oxagen Limited is a privately held UK biopharmaceutical company developing a pipeline of novel small molecule drugs addressing asthma and other chronic allergic and inflammatory โ€ฆSee details»

Oxagen Company Profile | Management and Employees List

Oxagen is a biopharmaceutical company building a novel drug pipeline based on targets validated in man through its genetics platform. The Company specialises in target identification and โ€ฆSee details»

Oxagen - 2025 Company Profile, Funding & Competitors - Tracxn

Apr 26, 2025 Oxagen has raised a total funding of $86.5M over 2 rounds. Its first funding round was on May 23, 2005. Its latest funding round was a Series C round on Nov 24, 2009 for โ€ฆSee details»

Oxagen Ltd. - Drug pipelines, Patents, Clinical trials - Synapse

Explore Oxagen Ltd. with its drug pipeline, therapeutic area, technology platform, 11 clinical trials, 2 news, and 30 literature, Drug:Timapiprant, ATX-2286. ... The statistics for drugs in the โ€ฆSee details»

Oxagen Company Profile - Office Locations, Competitors, Revenue โ€ฆ

Oxagen has 5 employees at their 1 location, $130.65 m in total funding, and £24.18 k in annual revenue in FY 2015. See insights on Oxagen including office locations, competitors, revenue, โ€ฆSee details»

Oxagen Limited: Contact Details and Business Profile - RocketReach

Oxagen is a biopharmaceutical company building a novel drug pipeline based on targets validated in man through its genetics platform. The Company specialises in target identification and โ€ฆSee details»

Oxagen Ltd. - BioCentury Company Profiles - BCIQ

Oxagen Ltd. - BioCentury Company Profiles for the biopharma industrySee details»

Oxagen Limited Raises £16 Million in Series C Private ... - BioSpace

Nov 24, 2009 About Oxagen Oxagen is a biopharmaceutical company building a novel drug pipeline with a focus on inflammatory and respiratory diseases. Oxagenโ€™s pipeline of novel โ€ฆSee details»

Oxagen Becomes First UK Genomics Co - Pharmaceutical industry โ€ฆ

Sep 24, 1997 Oxagen, the UK's first genomics company, has been established atAbingdon, near Oxford, England, by a group of former executives from British Biotech. James Noble, former โ€ฆSee details»

Oxagen | VentureRadar

Oxagen Limited is a privately held UK biopharmaceutical company developing a pipeline of novel small molecule drugs addressing asthma and other chronic allergic and inflammatory โ€ฆSee details»

Oxagen Ltd - Company Profile and News - Bloomberg Markets

Company profile page for Oxagen Ltd including stock price, company news, executives, board members, and contact informationSee details»

OXAGEN LIMITED - Companies House

OXAGEN LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activitySee details»

Oxagen company information, funding & investors | Dealroom.co

Oxagen, a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions. Here you'll find information about their funding, โ€ฆSee details»

House of Lords - Science and Technology - Written Evidence

Memorandum by Oxagen Ltd Oxagen is a Clinical Genomics Company investigating the genetic basis of common human disease to discover new diagnostics and better targeted therapies. โ€ฆSee details»

OXAGEN LIMITED people - Find and update company information

OXAGEN LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activitySee details»

Bill Gates - Co-Founder @ Oxagen - Crunchbase Person Profile

John Bell, MA, DM, FRCP is Founder of Oxagen Limited. Bell co-founded Wellcome Trust Centre for Human Genetics at the University of Oxford. He serves as Development Advisory Board โ€ฆSee details»

OXAGEN LIMITED insolvency - Find and update company โ€ฆ

More for OXAGEN LIMITED (03246469) 1 Insolvency case. Case number 1 โ€” Members voluntary liquidation . Commencement of winding up 31 October 2022 Declaration of solvency โ€ฆSee details»

Conservative Oxygen Therapy in Mechanically Ventilated Critically โ€ฆ

5 days ago Several clinical trials have shown no difference in outcome between a conservative compared with a more liberal approach to oxygen therapy in critically ill patients. 4-8 However, โ€ฆSee details»

linkstock.net © 2022. All rights reserved